Gaisberger, M. http://orcid.org/0000-0002-3757-5612
Fuchs, J.
Riedl, M.
Edtinger, S.
Reischl, R.
Grasmann, G.
Hölzl, B.
Landauer, F.
Dobias, H.
Eckstein, F.
Offenbächer, M.
Ritter, M.
Winklmayr, M. http://orcid.org/0000-0002-0896-3130
Funding for this research was provided by:
Paracelsus Medizinische Privatuniversität (PMU-FFF: R-16/01/076-DOB)
Article History
Received: 30 September 2020
Revised: 10 February 2021
Accepted: 10 February 2021
First Online: 1 March 2021
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Salzburg (415–E/1965/4–2015)
: All participants signed the informed consent
: Not applicable
: Felix Eckstein is CEO/CMO and co-owner of Chondrometrics GmbH; he has provided consulting services to Merck KGaA, Samumed, Kolon-Tissuegene, Servier, Galapagos, Roche, Novartis, and ICM. All other authors declare no conflict of interest.